SILK - Silk Road Medical Stock (SILK) Nosedives on CEO Departure and Revenue Shortfall | Benzinga
SAN FRANCISCO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Hagens Berman encourages Silk Road Medical, Inc. (NASDAQ:SILK) investors who suffered substantial losses to submit your losses now. Hagens Berman is investigating potential violations of the securities laws.
Visit: www.hbsslaw.com/investor-fraud/SILK
Contact An Attorney Now: SILK@hbsslaw.com
844-916-0895
Silk Road Medical, Inc. (NASDAQ:SILK) Investigation:
The investigation focuses on Silk Road's statements concerning financial risks to its business posed by the Centers for Medicare & Medicaid Services' ("CMS") July 2023 proposed National Coverage Determination ("NCD").
The NCD reportedly proposed to change coverage for a stroke treatment for ...
SILK) Nosedives on CEO Departure and Revenue Shortfall>Full story available on Benzinga.com